Physician profile
Giancarlo Checa
NPI 1003889833
$88,876.79
in general payments reported to CMS, 2019-2025
64 companies · $3,041 in 2025
The $3,041 reported for 2025 was more than what 98% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $27K · 2020: $2,571 · 2021: $4,192 · 2022: $35K · 2023: $11K · 2024: $6,258 · 2025: $3,041.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $14K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $5,100 · Travel and Lodging: $1,291.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $13,724.52 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $5,100.00 |
| Travel and Lodging | $1,290.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $65,489.36 | 2019-2025 | Wavewriter Alpha Prime 16, Intracept, General - Pain Management |
| Saluda Medical Americas, INC. | $4,000.17 | 2023-2025 | Evoke, Evoke Scs |
| Abbvie INC. | $1,480.22 | 2021-2025 | Qulipta, Ubrelvy, Botox |
| Mml US, INC. | $1,438.26 | 2022-2023 | Reactiv8 |
| Abbott Laboratories | $1,176.32 | 2019-2025 | Proclaim, Eterna |
| Southern Spine, LLC | $1,000.00 | 2022 | |
| Collegium Pharmaceutical, INC. | $990.30 | 2019-2025 | Xtampza, Belbuca, Nucynta |
| Allergan, INC. | $978.84 | 2019-2022 | |
| Scilex Pharmaceuticals INC. | $946.95 | 2019-2025 | Ztlido |
| Relievant Medsystems, INC. | $937.45 | 2022-2023 | Intracept |
| Medtronic, INC. | $896.70 | 2021-2024 | Intellis Adaptivestim, Accurian, Ellipsys Vascular Access System |
| Vertos Medical, INC. | $783.21 | 2020-2024 | Mild Device Kit |
| Painteq LLC | $779.23 | 2021-2024 | Painteq |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $629.14 | 2019-2025 | Relistor |
| Spr Therapeutics, INC | $534.55 | 2019-2024 | Sprint Pns System |
Show all 64 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Giancarlo Checa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.